Document is current
Any future updates will be listed below
-
Authors
Matoba, Ryo
Iijima, Hiroshi
Sakamoto, Yasuhiro
Kawabata, Ryohei
Ishiguro, Atsushi
Akamaru, Yusuke
Kito, Yosuke
Aizawa, Masaki
Matsuyama, Jin
Takahashi, Masazumi
Makiyama, Akitaka
Suzuki, Takahisa
Tsuda, Masahiro
Yasui, Hisateru
Hihara, Jun
Okuda, Hiroyuki
Kawada, Junji
Yoshioka, Takashi
Kawakami, Hisato
Eguchi Nakajima, Takako
Muro, Kei
Ichikawa, Wataru
Fujii, Masashi
Sunakawa, Yu
-
Funding
Funding for this research was provided by:
Ono Pharmaceutical
Bristol-Myers Squibb
Japan Clinical Cancer Research Organization
- License Information
-
More Information
Article History
Received: 19 October 2025
Accepted: 3 April 2026
First Online: 10 April 2026
Declarations
:
: The authors declare no competing interests.
: The authors declare that they have obtained appropriate approval from the Japan Clinical Cancer Research Organization Institutional Review Board and followed the principles outlined in the Declaration of Helsinki for all human experimental investigations. Informed consent was obtained from all participants at each institute.
